Get startedLog in
    Picture of Chosa Oncology AB logo

    CHOSA — Chosa Oncology AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: RhoVac AB Presents 3-Year Follow-Up Results Of The Phase I/II study In Prostate Cancer

    Picture of Chosa Oncology AB logoChosa Oncology AB
    05/10/2021 11:11
    Oct 5 (Reuters) - RhoVac AB  RHOVAC.TE :
    * RHOVAC PRESENTS 3-YEAR FOLLOW-UP RESULTS OF THE PHASE I/II
STUDY
IN PROSTATE CANCER

Source text for Eikon:  ID:nPrewMtRqa 
Further company coverage:  RHOVAC.TE

    Recent news on Chosa Oncology AB

    See all news